Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,550 | -20,732 | -84,553 | -36,120 | -22,509 |
| Depreciation Amortization | 3,959 | 1,546 | 6,467 | 4,821 | 3,051 |
| Accounts receivable | -109 | -8,157 | -184 | -21,031 | -604 |
| Accounts payable and accrued liabilities | -1,530 | -2,002 | -821 | -3,576 | 5,768 |
| Other Working Capital | 245,813 | -27,880 | -61,078 | -80,752 | -49,121 |
| Other Operating Activity | 24,368 | 18,303 | 44,368 | 52,117 | 12,300 |
| Operating Cash Flow | $224,951 | $-38,922 | $-95,801 | $-84,541 | $-51,115 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -40,000 | N/A | -278,964 | -193,964 | -180,523 |
| PPE Investments | -11,437 | -4,271 | -11,952 | -10,067 | -7,929 |
| Sale Of Investment | 47,545 | 34,429 | 50,138 | 29,148 | 19,603 |
| Investing Cash Flow | $-3,892 | $30,158 | $-240,778 | $-174,883 | $-168,849 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,735 | 5,102 | 257,948 | 256,943 | 254,811 |
| Financing Cash Flow | $7,735 | $5,102 | $257,948 | $256,943 | $254,811 |
| Exchange Rate Effect | N/A | N/A | 410 | N/A | N/A |
| Beginning Cash Position | 143,583 | 143,583 | 221,804 | 221,804 | 221,804 |
| End Cash Position | 372,377 | 139,921 | 143,583 | 219,323 | 256,651 |
| Net Cash Flow | $228,794 | $-3,662 | $-78,221 | $-2,481 | $34,847 |
| Free Cash Flow | |||||
| Operating Cash Flow | 224,951 | -38,922 | -95,801 | -84,541 | -51,115 |
| Capital Expenditure | -11,437 | -4,271 | -11,952 | -10,067 | -7,929 |
| Free Cash Flow | 213,514 | -43,193 | -107,753 | -94,608 | -59,044 |